Literature DB >> 17697637

Hereditary immunologic disorders caused by pyrin and cryopyrin.

Hal M Hoffman1.   

Abstract

A new family of hereditary immunologic disorders known as the autoinflammatory diseases involves dysregulation of the innate immune system. Elucidation of the genetic basis of these disorders has resulted in improved understanding of the disease pathophysiology of systemic and tissue inflammation, and has also revealed novel nonpathologic innate immune mechanisms. These advances have also resulted in direct improvement in diagnosis and therapy for autoinflammatory disorders such as the cryopyrinopathies and familial Mediterranean fever and have implications for more common inflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17697637     DOI: 10.1007/s11882-007-0049-4

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  55 in total

Review 1.  Genetic control of MHC class II expression.

Authors:  Jenny Pan-Yun Ting; John Trowsdale
Journal:  Cell       Date:  2002-04       Impact factor: 41.582

2.  Episodic evolution of pyrin in primates: human mutations recapitulate ancestral amino acid states.

Authors:  P Schaner; N Richards; A Wadhwa; I Aksentijevich; D Kastner; P Tucker; D Gumucio
Journal:  Nat Genet       Date:  2001-03       Impact factor: 38.330

Review 3.  Inborn and acquired abnormalities of the complement system of man.

Authors:  K F Austen
Journal:  Johns Hopkins Med J       Date:  1971-02

Review 4.  Familial autoinflammatory diseases: genetics, pathogenesis and treatment.

Authors:  Silvia Stojanov; Daniel L Kastner
Journal:  Curr Opin Rheumatol       Date:  2005-09       Impact factor: 5.006

Review 5.  Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation.

Authors:  Sanjeev Mariathasan; Denise M Monack
Journal:  Nat Rev Immunol       Date:  2007-01       Impact factor: 53.106

6.  Cutting edge: CATERPILLER: a large family of mammalian genes containing CARD, pyrin, nucleotide-binding, and leucine-rich repeat domains.

Authors:  Jonathan A Harton; Michael W Linhoff; Jinghua Zhang; Jenny P-Y Ting
Journal:  J Immunol       Date:  2002-10-15       Impact factor: 5.422

7.  The SPRY domain of Pyrin, mutated in familial Mediterranean fever patients, interacts with inflammasome components and inhibits proIL-1beta processing.

Authors:  S Papin; S Cuenin; L Agostini; F Martinon; S Werner; H-D Beer; C Grütter; M Grütter; J Tschopp
Journal:  Cell Death Differ       Date:  2007-04-13       Impact factor: 15.828

8.  Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. The International FMF Consortium.

Authors: 
Journal:  Cell       Date:  1997-08-22       Impact factor: 41.582

9.  Fine structure mapping of CIAS1: identification of an ancestral haplotype and a common FCAS mutation, L353P.

Authors:  Hal M Hoffman; Simon G Gregory; James L Mueller; Mark Tresierras; David H Broide; Alan A Wanderer; Richard D Kolodner
Journal:  Hum Genet       Date:  2002-11-16       Impact factor: 4.132

10.  Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist.

Authors:  Hal M Hoffman; Sanna Rosengren; David L Boyle; Jae Y Cho; Jyothi Nayar; James L Mueller; Justin P Anderson; Alan A Wanderer; Gary S Firestein
Journal:  Lancet       Date:  2004 Nov 13-19       Impact factor: 79.321

View more
  3 in total

Review 1.  Inflammasomes as polyvalent cell death platforms.

Authors:  Nathalia M de Vasconcelos; Nina Van Opdenbosch; Mohamed Lamkanfi
Journal:  Cell Mol Life Sci       Date:  2016-04-05       Impact factor: 9.261

2.  Necrotizing Funisitis as an Intrauterine manifestation of Cryopyrin-Associated Periodic Syndrome: a case report and review of the literature.

Authors:  Kyoko Yokoi; Sachiko Minamiguchi; Yoshitaka Honda; Mizuho Kobayashi; Satoru Kobayashi; Ryuta Nishikomori
Journal:  Pediatr Rheumatol Online J       Date:  2021-05-31       Impact factor: 3.054

3.  Rilonacept in the management of cryopyrin-associated periodic syndromes (CAPS).

Authors:  Justin Gillespie; Rebeccah Mathews; Michael F McDermott
Journal:  J Inflamm Res       Date:  2010-01-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.